Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
PJP
#6307
Invesco Pharmaceuticals ETF
106.5
3
USD
+2.20%
Sector:
Financial
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+2.20%
Monthly Change
+3.13%
6 month change
+14.88%
Year Change
+37.12%
Previous Close
104.2
4
Open
106.5
3
Bid
Ask
Low
106.4
8
High
106.5
3
Volume
4
Markets
US Stock Market
Financial
PJP
Open full chart
Top holdings
Market Value
Shares
Weight %
Invesco Private Prime Fund
29.41 M
29.41 M
10.62%
LLY
Eli Lilly and Co.
15.22 M
17.64 K
5.50%
TVTX
Travere Therapeutics, Inc.
14.28 M
406.04 K
5.16%
JNJ
Johnson & Johnson
13.89 M
73.56 K
5.02%
ABBV
AbbVie Inc.
13.59 M
62.31 K
4.91%
GILD
Gilead Sciences, Inc.
13.55 M
113.14 K
4.89%
AMGN
Amgen Inc.
13.38 M
44.83 K
4.83%
MRK
Merck & Co., Inc.
13.13 M
152.75 K
4.74%
PFE
Pfizer Inc.
12.84 M
520.96 K
4.64%
ABT
Abbott Laboratories
12.20 M
98.66 K
4.40%
Invesco Private Government Fund
11.30 M
11.30 M
4.08%
UTHR
United Therapeutics Corp.
10.20 M
22.90 K
3.68%
Avadel Pharmaceuticals PLC
9.01 M
476.86 K
3.25%
SUPN
Supernus Pharmaceuticals, Inc.
8.81 M
159.78 K
3.18%
LGND
Ligand Pharmaceuticals Inc.
8.48 M
44.33 K
3.06%
TARS
Tarsus Pharmaceuticals, Inc.
8.28 M
120.33 K
2.99%
AMRX
Amneal Pharmaceuticals, Inc.
8.17 M
754.94 K
2.95%
BIIB
Biogen Inc.
7.99 M
51.79 K
2.89%
REGN
Regeneron Pharmaceuticals, Inc.
7.85 M
12.05 K
2.84%
Jazz Pharmaceuticals PLC
7.80 M
56.65 K
2.82%
News
AI And The Future Of Healthcare
Global PMI: Tracking The Sectors Hit Hardest By The Middle East War
Can Forgotten Biotech Break Out?
Concerns Shift From Obsolescence To Oil
CDT Insider Sentiment March 2026: The Probability Race And Barbell Strategies
Trump's 100% Pharma Tariffs Will Have A Limited Effect On The Sector
Oil Shock Meets Asset Price Deflation
Finally Coming Into View? 'Old-Economy' Stocks Show Their Colors
Europe’s Last Chance To Revive Its Pharmaceutical Innovation Power
Q4 2025 Earnings: AI Disruption Vs. Traditional Fundamentals
Pharma's Godfather Moment: Pulled Back Into Tariff Uncertainty
The K-Shaped Consumer Economy: GLP-1s, AI And The Future Of Consumer Spending